We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCAI
1576
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $425K | ﹤0.01% |
9,198
+2,611
| +40% | +$116K |
|
1577
Herbalife
HLF
$1.26B
| $424K | ﹤0.01% |
17,596
-108,692
| -86% | -$2.97M |
|
1578
Virtus Investment Partners
VRTS
$1.12B
| $422K | ﹤0.01% |
3,573
-6,851
| -66% | -$748K |
|
|
PMC
1579
DELISTED
PharMerica Corporation
PMC
| $422K | ﹤0.01% |
16,742
-12,169
| -42% | -$307K |
|
1580
POSCO
PKX
$16.1B
| $420K | ﹤0.01% |
7,994
-8,154
| -50% | -$438K |
|
1581
Rexford Industrial Realty
REXR
$8.63B
| $420K | ﹤0.01% |
+18,100
| New | +$397K |
|
1582
Cinemark Holdings
CNK
$3.93B
| $417K | ﹤0.01% |
10,895
-6,725
| -38% | -$268K |
|
1583
VanEck Semiconductor ETF
SMH
$66.1B
| $416K | ﹤0.01% |
+11,600
| New | +$405K |
|
1584
AGCO
AGCO
$8.71B
| $415K | ﹤0.01% |
7,172
-5,958
| -45% | -$322K |
|
1585
AGNC Investment
AGNC
$12.4B
| $412K | ﹤0.01% |
+22,699
| New | +$430K |
|
1586
H.B. Fuller
FUL
$3.04B
| $411K | ﹤0.01% |
8,494
-392
| -4% | -$18.2K |
|
1587
HSBC
HSBC
$357B
| $411K | ﹤0.01% |
+11,312
| New | +$401K |
|
1588
Caesarstone
CSTE
$75.7M
| $408K | ﹤0.01% |
+14,220
| New | +$451K |
|
|
LTC
1589
LTC Properties
LTC
$2.15B
| $407K | ﹤0.01% |
+8,654
| New | +$409K |
|
|
GNCMA
1590
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $407K | ﹤0.01% |
+20,942
| New | +$346K |
|
1591
Synaptics
SYNA
$4.55B
| $404K | ﹤0.01% |
7,539
-20,012
| -73% | -$1.16M |
|
|
VSI
1592
DELISTED
Vitamin Shoppe Inc.
VSI
| $404K | ﹤0.01% |
+17,046
| New | +$437K |
|
1593
Ares Capital
ARCC
$13.6B
| $402K | ﹤0.01% |
+24,400
| New | +$384K |
|
1594
Fair Isaac
FICO
$29.7B
| $402K | ﹤0.01% |
3,369
-10,676
| -76% | -$1.27M |
|
1595
CALL
Tractor Supply
TSCO
$16.7B
| $402K | ﹤0.01% |
26,500
-33,500
| -56% | -$476K |
|
1596
Ball Corp
BALL
$17.2B
| $401K | ﹤0.01% |
10,682
-57,994
| -84% | -$2.24M |
|
|
HT
1597
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $399K | ﹤0.01% |
18,567
-36,785
| -66% | -$718K |
|
|
COOP
1598
DELISTED
Mr. Cooper
COOP
| $398K | ﹤0.01% |
21,368
+8,868
| +71% | +$191K |
|
|
BEAV
1599
DELISTED
B/E Aerospace Inc
BEAV
| $397K | ﹤0.01% |
6,600
-10,980
| -62% | -$632K |
|
|
TIF
1600
DELISTED
Tiffany & Co.
TIF
| $396K | ﹤0.01% |
5,119
-6,197
| -55% | -$477K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.